Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.

Birnbaum HG, Kessler RC, Lowe SW, Secnik K, Greenberg PE, Leong SA, Swensen AR.

Curr Med Res Opin. 2005 Feb;21(2):195-206.

PMID:
15801990
2.

The economic impact of attention-deficit/hyperactivity disorder in children and adolescents.

Pelham WE, Foster EM, Robb JA.

Ambul Pediatr. 2007 Jan-Feb;7(1 Suppl):121-31. Review.

PMID:
17261491
3.

The economic impact of attention-deficit/hyperactivity disorder in children and adolescents.

Pelham WE, Foster EM, Robb JA.

J Pediatr Psychol. 2007 Jul;32(6):711-27. Epub 2007 Jun 7. Review.

PMID:
17556402
4.

Economic costs of diabetes in the U.S. In 2007.

American Diabetes Association.

Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Review. Erratum in: Diabetes Care. 2008 Jun;31(6):1271.

PMID:
18308683
5.

[Overall burden to society caused by hyperkinetic syndrome (HKS) and attention deficit hyperactivity disorder (ADHD)].

Schöffski O, Sohn S, Happich M.

Gesundheitswesen. 2008 Jul;70(7):398-403. doi: 10.1055/s-0028-1082049. Review. German.

PMID:
18729028
6.

Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States.

Doshi JA, Hodgkins P, Kahle J, Sikirica V, Cangelosi MJ, Setyawan J, Erder MH, Neumann PJ.

J Am Acad Child Adolesc Psychiatry. 2012 Oct;51(10):990-1002.e2. doi: 10.1016/j.jaac.2012.07.008. Epub 2012 Sep 5. Review.

PMID:
23021476
7.

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.

Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. Review.

8.

Impact of comorbidity in adults with attention-deficit/hyperactivity disorder.

Biederman J.

J Clin Psychiatry. 2004;65 Suppl 3:3-7. Review.

9.

[Direct and indirect diabetes costs in the world].

Logminiene Z, Norkus A, Valius L.

Medicina (Kaunas). 2004;40(1):16-26. Review. Lithuanian.

10.

Assessment of the economic burden of COPD in the U.S.: a review and synthesis of the literature.

Foster TS, Miller JD, Marton JP, Caloyeras JP, Russell MW, Menzin J.

COPD. 2006 Dec;3(4):211-8. Review.

PMID:
17361502
11.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
12.
13.

[Detailed review of epidemiologic studies on adult Attention Deficit/Hyperactivity Disorder (ADHD)].

Simon V, Czobor P, Bálint S, Mészáros A, Murai Z, Bitter I.

Psychiatr Hung. 2007;22(1):4-19. Review. Hungarian.

PMID:
17558040
14.

Estimating the cost of epilepsy in Europe: a review with economic modeling.

Pugliatti M, Beghi E, Forsgren L, Ekman M, Sobocki P.

Epilepsia. 2007 Dec;48(12):2224-33. Review.

15.

A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.

Kollins SH.

Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908X280707 . Epub 2008 Apr 1. Review.

PMID:
18384709
16.

Recognizing ADHD in adults with comorbid mood disorders: implications for identification and management.

Goodman DW, Thase ME.

Postgrad Med. 2009 Sep;121(5):20-30. doi: 10.3810/pgm.2009.09.2049. Review.

PMID:
19820271
17.

The economic impact of schizophrenia.

Rice DP.

J Clin Psychiatry. 1999;60 Suppl 1:4-6; discussion 28-30. Review.

18.

The search for biomarkers for attention deficit/hyperactivity disorder.

Wallis D.

Drug News Perspect. 2010 Sep;23(7):438-49. doi: 10.1358/dnp.2010.23.7.1472296. Review.

PMID:
20862396
19.
20.

Economic implications of attention-deficit hyperactivity disorder for healthcare systems.

Leibson CL, Long KH.

Pharmacoeconomics. 2003;21(17):1239-62. Review.

PMID:
14986737

Supplemental Content

Support Center